AMZN
Amazon.com, Inc.
AMZN has the edge over UFI overall, supported by stronger valuation and lower modeled downside.
UFI
Unifi, Inc.
UFI's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
UFI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Under pressure |
UFI's cash flow is currently healthy, and its revenue and profitability are stable, but its balance sheet is under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
UFI PE Valuation
UFI has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 31x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
UFI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect UFI to return to profit, with revenue growing.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over UFI on earnings quality, reporting a profit while its opponent remains loss making.
UFI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.22 | — |
| Q3 2026 | -$0.82 | +$0.52 |
| Q2 2026 | -$1.33 | -$0.19 |
| Q1 2026 | -$0.45 | +$1.73 |
| Q4 2025 | -$1.25 | +$0.58 |
| Q3 2025 | -$1.34 | +$0.97 |
| Q2 2025 | -$1.14 | +$1.48 |
| Q1 2025 | -$2.18 | +$1.07 |
| Q4 2024 | -$1.83 | +$1.14 |
UFI is still losing money, but far less than before: $0.82 per share over the past year, against $3.25 at its worst in early 2024.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over UFI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over UFI on profitability, with a higher operating margin.
UFI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $127.9M | -5.7% |
| Q2 2026 | $144.2M | +4.1% |
| Q1 2026 | $130M | -11% |
| Q4 2025 | $121.4M | -13% |
| Q3 2025 | $135.7M | -7.9% |
| Q2 2025 | $138.5M | -12% |
| Q1 2025 | $146.6M | -1.6% |
| Q4 2024 | $138.9M | +1.4% |
UFI's revenue has slid since its 2022 peak: $128M last quarter, down 5.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0% | +7.1 points |
| Q2 2026 | 1.6% | -9.3 points |
| Q1 2026 | -0.1% | +9.4 points |
| Q4 2025 | -6% | -0.5 points |
| Q3 2025 | -7.1% | -4.9 points |
| Q2 2025 | 11% | +11 points |
| Q1 2025 | -9.5% | -4.8 points |
| Q4 2024 | -5.5% | +7.4 points |
UFI's operating margin was −0% last quarter, up 7.1 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
UFI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.5M | +$13.4M |
| Q2 2026 | $1M | +$4.9M |
| Q1 2026 | $7.2M | +$15.2M |
| Q4 2025 | $24.2M | +$29.3M |
| Q3 2025 | -$10.9M | +$3.9M |
| Q2 2025 | -$3.9M | -$2.2M |
| Q1 2025 | -$8M | -$4M |
| Q4 2024 | -$5.1M | +$2.6M |
UFI has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over UFI on leverage, with a lower net debt burden relative to earnings.
UFI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.5x | Elevated |
| Q2 2026 | 7.2x | High |
| Q1 2026 | 3.1x | Elevated |
| Q4 2025 | 8.7x | High |
| Q3 2025 | 11.4x | High |
| Q2 2025 | 5.4x | High |
| Q1 2025 | 197.4x | High |
| Q4 2024 | 14.5x | High |
UFI's net debt is about 3.5 years of its operating earnings (EBITDA), down from 11 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
UFI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.6 | Neutral |
| Stochastic | 24.9 | Neutral |
UFI's weekly RSI is 60 (neutral) and its Stochastic is 25 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
UFI PE vs Consumer Cyclical Sector
| Metric | UFI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
UFI has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
UFI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.10 | 10% above |
| 20 week MA | $6.40 | 5.3% above |
| 50 week MA | $4.86 | 39% above |
| 100 week MA | $4.88 | 38% above |
| 200 week MA | $5.87 | 15% above |
UFI has climbed back above all five of its weekly moving averages, and it's now 15% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
UFI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $25.0 | $17.1 | -32% |
| 2021 | $17.1 | $22.8 | +33% |
| 2022 | $22.8 | $7.91 | -65% |
| 2023 | $7.91 | $6.66 | -16% |
| 2024 | $6.66 | $5.71 | -14% |
| 2025 | $5.71 | $3.38 | -41% |
| 2026 YTD | $3.38 | $6.74 | +99% |
UFI has the edge over AMZN on returns for 2026, with the stronger performance.